• Fri news: Iterum’s UTI drug. Edwards layoffs. Zenas BioPharma IPO. GSK’s Nucala hits COPD target. Pharma layoff stories. See more on our front page

Lay offs

















































No warning no scheduled call it stinks How is it obu had a huge change and bcbu increases rml’s and kam’s for repatha which isn’t doing well. One drug and not meeting or reaching quotas
 












These are not the first cuts. There will be a second and third phase. As usual when ZS is running the show with restricting field sales.
6-months
18 months

Watch out for tracking and MBO trackers.
 




Welcome to big pharma culture. Make quarterly numbers by buying back stock and cutting heads. Oh and don’t forget overpaying for acquisitions with instant buyers remorse in the form of more cuts.
 




Welcome to big pharma culture. Make quarterly numbers by buying back stock and cutting heads. Oh and don’t forget overpaying for acquisitions with instant buyers remorse in the form of more cuts.

We've been buying back stock for years. Are you not aware? It's a good use of cash when we have excess and nothing better to do with it at the moment. And wall street clearly agrees. You're not an expert on the matter.

Cutting heads is needed when sales are flat or declining and people are not performing. And frankly so many people here don't do shit. I have worked at smaller companies and the same thing happens. You don't produce you go. Or if you're not needed you go. Sorry but that's life. This isn't a nonprofit.

Your opinion of if we overpaid for an acquisition if highly subjective and based on extremely limited information. It is funny to me that you and many others think they know more than people who spent months analyzing the deal, running the numbers, with far more information than you, who do this for their job, and they found a reason to do this deal, when they turn down 99% of all other deals. Clearly they believe it to be important to growing sales especially in the short term and accretive to the P&L, with a portfolio that's otherwise stagnant those are critical considerations, not just what wall street values it at. And by the way, we have a large tax break on otetzla people keep forgetting. Everyone here needs to stop thinking they can do everyone else's job better and do your own job better. Maybe then you wouldn't have been fired.
 




We've been buying back stock for years. Are you not aware? It's a good use of cash when we have excess and nothing better to do with it at the moment. And wall street clearly agrees. You're not an expert on the matter.

Cutting heads is needed when sales are flat or declining and people are not performing. And frankly so many people here don't do shit. I have worked at smaller companies and the same thing happens. You don't produce you go. Or if you're not needed you go. Sorry but that's life. This isn't a nonprofit.

Your opinion of if we overpaid for an acquisition if highly subjective and based on extremely limited information. It is funny to me that you and many others think they know more than people who spent months analyzing the deal, running the numbers, with far more information than you, who do this for their job, and they found a reason to do this deal, when they turn down 99% of all other deals. Clearly they believe it to be important to growing sales especially in the short term and accretive to the P&L, with a portfolio that's otherwise stagnant those are critical considerations, not just what wall street values it at. And by the way, we have a large tax break on otetzla people keep forgetting. Everyone here needs to stop thinking they can do everyone else's job better and do your own job better. Maybe then you wouldn't have been fired.

thank you mr CSUN